(Sept 14, Reuters): Indonesia stocks rose over 2% on Monday after new Covid-19 restrictions on Jakarta proved less severe than feared, with markets across Asia aided by AstraZeneca resuming trials of its leading vaccine candidate.
South Korean stocks led gains outside Indonesia, rising more than 1% while other markets edged higher ahead of a flurry of potential catalysts this week.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
